Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMT

Abstract

Jian Sun, Weiwei Sheng, Yuteng Ma, Ming Dong Department of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, People’s Republic of ChinaCorrespondence: Ming DongDepartment of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, People’s Republic of ChinaTel [phone]Fax [phone]Email [email protected]: Local invasion and distant metastasis are the key hallmarks in the aggressive progression of malignant tumors, including the ability of cancer cells to detach from the extracellular matrix overcome apoptosis, and disseminate into distant sites. It is generally believed that this malignant behavior is stimulated by epithelial-mesenchymal transition (EMT). Musashi (MSI) RNA-binding proteins, belonging to the evolutionarily conserved RNA-binding proteins (RBP) family, were originally discovered to regulate asymmetric cell division during embryonic development. Recently, Musashi-2 (MSI2), as a key member of MSI family, has been prevalently reported to be tightly associated with the advanced clinical stage of several cancers. Multiple oncogenic signaling pathways mediated by MSI2 play vital roles in EMT. Here, we systematically reviewed the detailed role and signal networks of MSI2 in regulating cancer development, especially in EMT signal transduction, involving EGF, TGF-β, Notch, and Wnt pathways.Keywords: Musashi-2, EMT, EGF, TGF-β, notch, Wnt, targeted therapy

Keywords

• musashi-2
• emt
• egf
• tgf-β
• notch
• wnt
• targeted therapy